Indian Drug Research
-
{
- All
- News
- Videos
-
Antibiotic Resistance vs Antibiotic Tolerance: Why Knowing The Difference Matters
Antibiotic resistance and antibiotic tolerance have their distinct effect on your system. Knowing their differences is key to understanding how careful you need to be with antibiotics.
-
IIT Gandhinagar Develops Hydrogel-Based Technology To Simplify Colon Tumour Surgery
Gandhinagar, April 19 (IANS) In a landmark achievement, the IIT Gandhinagar has developed a hydrogel-based technology with potential of spurring further innovations -- thereby resulting in "simplification" of surgery for colon-related tumours.
-
Indian Researchers Unlock Bacterial Genetic Code To Combat Tuberculosis
New Delhi, April 2 (IANS) Tuberculosis is one of the world’s deadliest infectious diseases and now, a team of scientists has discovered a fundamental flaw in a long-standing model of how bacteria control gene expression that can form the base for inn
-
Delhi Scientists Deploy AI To Advance Drug Development For Pneumonia
A new India-Sweden research collaboration at Indraprastha Institute of Information Technology, Delhi is using artificial intelligence to help scientists outpace deadly pneumonia germs.
-
Can Antibodies From Camels Help Develop Dengue Vaccines? Researchers From Mohali Reveal
Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies from camels may help neutralise the dengue virus. Scientists say these tiny "nanobodies" could pave the way for future dengue tr
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Budget 2026: India's Evidence-Based Holistic Healthcare Ecosystem Gets A Boost, Says Ayush Minister
The Union Budget announcements link health policy with rural livelihoods, export growth, youth employment and entrepreneurship — strengthening Indias emergence as the world capital of evidence-based holistic healthcare, Ayush
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
-
Antibiotic Resistance vs Antibiotic Tolerance: Why Knowing The Difference Matters
Antibiotic resistance and antibiotic tolerance have their distinct effect on your system. Knowing their differences is key to understanding how careful you need to be with antibiotics.
-
IIT Gandhinagar Develops Hydrogel-Based Technology To Simplify Colon Tumour Surgery
Gandhinagar, April 19 (IANS) In a landmark achievement, the IIT Gandhinagar has developed a hydrogel-based technology with potential of spurring further innovations -- thereby resulting in "simplification" of surgery for colon-related tumours.
-
Indian Researchers Unlock Bacterial Genetic Code To Combat Tuberculosis
New Delhi, April 2 (IANS) Tuberculosis is one of the world’s deadliest infectious diseases and now, a team of scientists has discovered a fundamental flaw in a long-standing model of how bacteria control gene expression that can form the base for inn
-
Delhi Scientists Deploy AI To Advance Drug Development For Pneumonia
A new India-Sweden research collaboration at Indraprastha Institute of Information Technology, Delhi is using artificial intelligence to help scientists outpace deadly pneumonia germs.
-
Can Antibodies From Camels Help Develop Dengue Vaccines? Researchers From Mohali Reveal
Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies from camels may help neutralise the dengue virus. Scientists say these tiny "nanobodies" could pave the way for future dengue tr
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Budget 2026: India's Evidence-Based Holistic Healthcare Ecosystem Gets A Boost, Says Ayush Minister
The Union Budget announcements link health policy with rural livelihoods, export growth, youth employment and entrepreneurship — strengthening Indias emergence as the world capital of evidence-based holistic healthcare, Ayush
-
Health Ministry Amends Rules To Ease Drug Research, Cut Regulatory Delays By 90 Days
The Union Health Ministry has amended the NDCT Rules, 2019 to reduce regulatory burden, waive permissions for low-risk studies, and speed up drug development timelines by at least 90 days, boosting pharmaceutical R&D in India.
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
